Erratum: The oral VEGF receptor tyrosine kinase inhibitor pazopanib in combination with the MEK inhibitor trametinib in advanced cholangiocarcinoma (British journal of cancer (2017) 116 11 (1402-1407))

Rachna T. Shroff; Mark Yarchoan; Ashley O'Connor; Denise Gallagher; Marianna L. Zahurak; Gary Rosner; Chimela Ohaji; Susan Sartorius-Mergenthaler; Rose Parkinson; Vivek Subbiah; Ralph Zinner; Nilofer S. Azad

doi:10.1038/bjc.2017.418

Erratum: The oral VEGF receptor tyrosine kinase inhibitor pazopanib in combination with the MEK inhibitor trametinib in advanced cholangiocarcinoma (British journal of cancer (2017) 116 11 (1402-1407))

Rachna T. Shroff
, Mark Yarchoan
, Ashley O'Connor
, Denise Gallagher
, Marianna L. Zahurak
, Gary Rosner
, Chimela Ohaji
, Susan Sartorius-Mergenthaler
, Rose Parkinson
, Vivek Subbiah
, Ralph Zinner
, Nilofer S. Azad

Research output: Contribution to journal › Comment/debate

3 Scopus citations

Original language	English
Pages (from-to)	e2
Journal	British Journal of Cancer
Volume	118
Issue number	2
DOIs	https://doi.org/10.1038/bjc.2017.418
State	Published - Jan 1 2018

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

ASJC Scopus subject areas

Oncology
Cancer Research

Access to Document

10.1038/bjc.2017.418

Cite this

Shroff, R. T., Yarchoan, M., O'Connor, A., Gallagher, D., Zahurak, M. L., Rosner, G., Ohaji, C., Sartorius-Mergenthaler, S., Parkinson, R., Subbiah, V., Zinner, R., & Azad, N. S. (2018). Erratum: The oral VEGF receptor tyrosine kinase inhibitor pazopanib in combination with the MEK inhibitor trametinib in advanced cholangiocarcinoma (British journal of cancer (2017) 116 11 (1402-1407)). British Journal of Cancer, 118(2), e2. https://doi.org/10.1038/bjc.2017.418

@article{e6e65501b20344078976b74b94858524,

title = "Erratum: The oral VEGF receptor tyrosine kinase inhibitor pazopanib in combination with the MEK inhibitor trametinib in advanced cholangiocarcinoma (British journal of cancer (2017) 116 11 (1402-1407))",

author = "Shroff, \{Rachna T.\} and Mark Yarchoan and Ashley O'Connor and Denise Gallagher and Zahurak, \{Marianna L.\} and Gary Rosner and Chimela Ohaji and Susan Sartorius-Mergenthaler and Rose Parkinson and Vivek Subbiah and Ralph Zinner and Azad, \{Nilofer S.\}",

year = "2018",

month = jan,

day = "1",

doi = "10.1038/bjc.2017.418",

language = "English",

volume = "118",

pages = "e2",

number = "2",

}

Shroff, RT, Yarchoan, M, O'Connor, A, Gallagher, D, Zahurak, ML, Rosner, G, Ohaji, C, Sartorius-Mergenthaler, S, Parkinson, R, Subbiah, V, Zinner, R & Azad, NS 2018, 'Erratum: The oral VEGF receptor tyrosine kinase inhibitor pazopanib in combination with the MEK inhibitor trametinib in advanced cholangiocarcinoma (British journal of cancer (2017) 116 11 (1402-1407))', British Journal of Cancer, vol. 118, no. 2, pp. e2. https://doi.org/10.1038/bjc.2017.418

Erratum: The oral VEGF receptor tyrosine kinase inhibitor pazopanib in combination with the MEK inhibitor trametinib in advanced cholangiocarcinoma (British journal of cancer (2017) 116 11 (1402-1407)). / Shroff, Rachna T.; Yarchoan, Mark; O'Connor, Ashley et al.
In: British Journal of Cancer, Vol. 118, No. 2, 01.01.2018, p. e2.

Research output: Contribution to journal › Comment/debate

TY - JOUR

T1 - Erratum

T2 - The oral VEGF receptor tyrosine kinase inhibitor pazopanib in combination with the MEK inhibitor trametinib in advanced cholangiocarcinoma (British journal of cancer (2017) 116 11 (1402-1407))

AU - Shroff, Rachna T.

AU - Yarchoan, Mark

AU - O'Connor, Ashley

AU - Gallagher, Denise

AU - Zahurak, Marianna L.

AU - Rosner, Gary

AU - Ohaji, Chimela

AU - Sartorius-Mergenthaler, Susan

AU - Parkinson, Rose

AU - Subbiah, Vivek

AU - Zinner, Ralph

AU - Azad, Nilofer S.

PY - 2018/1/1

Y1 - 2018/1/1

UR - https://www.scopus.com/pages/publications/85076685455

UR - https://www.scopus.com/pages/publications/85076685455#tab=citedBy

U2 - 10.1038/bjc.2017.418

DO - 10.1038/bjc.2017.418

M3 - Comment/debate

C2 - 29315294

AN - SCOPUS:85076685455

SN - 0007-0920

VL - 118

SP - e2

JO - British Journal of Cancer

JF - British Journal of Cancer

IS - 2

ER -

Erratum: The oral VEGF receptor tyrosine kinase inhibitor pazopanib in combination with the MEK inhibitor trametinib in advanced cholangiocarcinoma (British journal of cancer (2017) 116 11 (1402-1407))

UN SDGs

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this